Unclaimed Scholar Profile
Are you Shaun Lawrence Barnabas? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-7156-0556-9444 orcid.org/0000-0002-4819-9501
Shaun Lawrence Barnabas
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Reproductive tract infections research#HIV/AIDS Research and Interventions#Cervical Cancer and HPV Research#Gut microbiota and health
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 10,056 | 4,827 |
| h-index | 27 | 20 |
| i10-index | 42 | 29 |
Annual Citation Growth
Verified Citations / Year0
2020483
2021+40%676
2022+29%869
2023+33%1.2k
2024-8%1.1k
2025-45%579
2026Scholarship Distribution & Proportions94 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (8,246) • 18% Global Research Impact (1,810)
94 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (94)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Published in New England Journal of Medicine•2023
DOI: 10.1056/nejmoa2216480 Verified Peer-Reviewed
High Asymptomatic Carriage With the Omicron Variant in South Africa
Published in Clinical Infectious Diseases•2022
DOI: 10.1093/cid/ciac237 Verified Peer-Reviewed
Showing 1 – 5 of 94 publications
1 / 19